国际肿瘤学杂志 ›› 2012, Vol. 39 ›› Issue (7): 510-513.

• 综述 • 上一篇    下一篇

癌性恶病质的诊断和治疗

刘子凤,李贵新   

  1. 潍坊医学院肿瘤学教研室
  • 出版日期:2012-08-06 发布日期:2012-08-06
  • 通讯作者: 李贵新,E-mail:liguixin@tom.com E-mail:liguixin@tom.com

Cancer cachexia diagnosis and therapy

LIU  Zi-Feng, LI  Gui-Xin   

  1. Department of Oncology of Weifang Medical College, Weifang 261053, China
  • Online:2012-08-06 Published:2012-08-06
  • Contact: LI Gui-xin, E-mail: liguixin@tom.com E-mail:liguixin@tom.com

摘要: 癌性恶病质传统的治疗方法一般在晚期进行干预,以增加营养摄入为主,并且多以体重做为判断疗效的标准,大量临床试验证明效果并不理想。最近的研究表明在恶病质早期即以蛋白酶体为靶点进行靶向治疗,并与传统治疗相结合,治疗后核因子-κB(NF-κB)水平降低,肌纤维蛋白破坏终止,血浆蛋白及瘦体数量升高,功能好转。

关键词: 恶病质, 诊断, 肿瘤分期, 蛋白酶体

Abstract: Cancer cachexia (CC) caused by cancer is a syndrome with complicated symptoms. Traditional therapies usually give interventions for more nutrition intake at CC late stage and take weight as the outcome marker. Lots of clinical trials demonstrate that the effect is not satisfactory. Recent studies show that the level of NF-κB decreased, termination of the breakdown of myofibrillar proteins, the serum proteins and lean body mass increased and function improvement after targeting proteasome at early stage of CC combined with traditional therapy. 

Key words: Cachexia, Diagnosis, Neoplasm staging, Proteasome